Hadiloo K, Tahmasebi S, Esmaeilzadeh A
Cancer Cell Int. 2023; 23(1):86.
PMID: 37158883
PMC: 10165596.
DOI: 10.1186/s12935-023-02923-9.
Nakashima H, Kinoshita M
J Clin Med. 2023; 12(3).
PMID: 36769513
PMC: 9917438.
DOI: 10.3390/jcm12030866.
Joyce S, Okoye G, Van Kaer L
Crit Rev Immunol. 2022; 41(4):55-88.
PMID: 35381143
PMC: 11078124.
DOI: 10.1615/CritRevImmunol.2021040076.
Watanabe A, Yamashita K, Fujita M, Arimoto A, Nishi M, Takamura S
Cancers (Basel). 2022; 14(1).
PMID: 35008335
PMC: 8750915.
DOI: 10.3390/cancers14010171.
Nelson A, Lukacs J, Johnston B
Cancers (Basel). 2021; 13(20).
PMID: 34680322
PMC: 8533824.
DOI: 10.3390/cancers13205174.
Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression.
Nakamura M, Meguri Y, Ikegawa S, Kondo T, Sumii Y, Fukumi T
Sci Rep. 2021; 11(1):13125.
PMID: 34162921
PMC: 8222309.
DOI: 10.1038/s41598-021-92526-z.
Invariant natural killer T cells balance B cell immunity.
Leadbetter E, Karlsson M
Immunol Rev. 2021; 299(1):93-107.
PMID: 33438287
PMC: 8485762.
DOI: 10.1111/imr.12938.
Spatial distribution of IL4 controls iNKT cell-DC crosstalk in tumors.
Wang L, Liu Z, Wang L, Wu Q, Li X, Xie D
Cell Mol Immunol. 2019; 17(5):496-506.
PMID: 31160756
PMC: 7192838.
DOI: 10.1038/s41423-019-0243-z.
Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response.
Sartorius R, DApice L, Barba P, Cipria D, Grauso L, Cutignano A
Front Immunol. 2018; 9:1496.
PMID: 30002659
PMC: 6031736.
DOI: 10.3389/fimmu.2018.01496.
Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective.
Kumar A, Suryadevara N, Hill T, Bezbradica J, Van Kaer L, Joyce S
Front Immunol. 2018; 8:1858.
PMID: 29312339
PMC: 5743650.
DOI: 10.3389/fimmu.2017.01858.
Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.
Keller C, Freigang S, Lunemann J
Front Immunol. 2017; 8:570.
PMID: 28596767
PMC: 5442181.
DOI: 10.3389/fimmu.2017.00570.
Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza.
Barthelemy A, Ivanov S, Hassane M, Fontaine J, Heurtault B, Frisch B
mBio. 2016; 7(6).
PMID: 27803187
PMC: 5090038.
DOI: 10.1128/mBio.01440-16.
Selective Conditions Are Required for the Induction of Invariant NKT Cell Hyporesponsiveness by Antigenic Stimulation.
Wingender G, Birkholz A, Sag D, Farber E, Chitale S, Howell A
J Immunol. 2015; 195(8):3838-48.
PMID: 26355152
PMC: 4592824.
DOI: 10.4049/jimmunol.1500203.
Border Patrol Gone Awry: Lung NKT Cell Activation by Francisella tularensis Exacerbates Tularemia-Like Disease.
Hill T, Gilchuk P, Cicek B, Osina M, Boyd K, Durrant D
PLoS Pathog. 2015; 11(6):e1004975.
PMID: 26068662
PMC: 4465904.
DOI: 10.1371/journal.ppat.1004975.
Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice.
Gebremeskel S, Clattenburg D, Slauenwhite D, Lobert L, Johnston B
Oncoimmunology. 2015; 4(3):e995562.
PMID: 25949924
PMC: 4404817.
DOI: 10.1080/2162402X.2014.995562.
The regulatory role of invariant NKT cells in tumor immunity.
McEwen-Smith R, Salio M, Cerundolo V
Cancer Immunol Res. 2015; 3(5):425-35.
PMID: 25941354
PMC: 4430818.
DOI: 10.1158/2326-6066.CIR-15-0062.
A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens.
Arora P, Baena A, Yu K, Saini N, Kharkwal S, Goldberg M
Immunity. 2014; 40(1):105-16.
PMID: 24412610
PMC: 3895174.
DOI: 10.1016/j.immuni.2013.12.004.
B Cells Promote Th1- Skewed NKT Cell Response by CD1d-TCR Interaction.
Shin J, Park S
Immune Netw. 2013; 13(5):218-21.
PMID: 24198748
PMC: 3817304.
DOI: 10.4110/in.2013.13.5.218.
Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection.
Aspeslagh S, Nemcovic M, Pauwels N, Venken K, Wang J, Van Calenbergh S
J Immunol. 2013; 191(6):2916-25.
PMID: 23960235
PMC: 3817951.
DOI: 10.4049/jimmunol.1203134.
Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro.
Zeng S, Ghnewa Y, OReilly V, Lyons V, Atzberger A, Hogan A
J Immunol. 2013; 191(4):1666-76.
PMID: 23851681
PMC: 4201948.
DOI: 10.4049/jimmunol.1202223.